Top 10 Medical AI Companies to Buy According to Analysts

6. Evolent Health, Inc. (NYSE:EVH)

Stock Upside Potential: 50.30%

Number of Hedge Fund Holders: 37

Evolent Health, Inc. (NYSE:EVH) is one of the top 10 medical AI companies to buy according to analysts. On July 9, the company strengthened its leadership team with the appointment of Dr. David Lim as chief clinical officer and John Way as CFO of its Performance Suite.

Dr. Lim is tasked with leading Evolent’s 300-person Health team, which focuses on innovation. He joins the team with deep experience, having previously served as the Chief Medical Officer at RightMove Health. He has also served as the Chief Technology Innovation Officer at InnovaCare Health.

Way will oversee the company’s financial aspects, focusing on the at-risk specialty condition management product. He joins Evolent Health with over 20 years of experience in executive financial management.

“I’m excited to welcome Dave and John, not just because of their deep experience but also their commitment to transforming specialty care for patients, payers and providers,” said Seth Bleckley, CEO and Co-Founder of Evolent.

Evolent Health, Inc. (NYSE:EVH) utilizes AI to enhance its healthcare solutions, particularly in areas like utilization management and clinical workflow automation. It has already acquired Machinify’s AI-powered utilization management products to streamline clinical workflows and improve efficiency in specialty condition management.